Omni
Omni ships weekly, and almost every week the headline item is an AI feature.
A side-by-side editorial comparison of ibdsim2 and Plotly — release velocity, themes, recent moves, and the top alternatives to consider.
A pedigree IBD simulator that absorbed its own web app and now optimises for dense marker panels.
ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
Plotly ships on two tracks. Plotly Studio, the desktop AI app-builder, releases every one to two weeks and has spent v0.0.80 through v0.0.86 on credential handling, reasoning transparency, personalization and now the reliability of the agent session engine itself. Plotly Cloud is the louder track: since late May it has added viewer-seat pricing, domain verification, per-app compute modes with credit-metered billing, and customer-owned domains with managed TLS.
ibdsim2 simulates identity-by-descent sharing along chromosomes for arbitrary pedigrees, in both autosomal and X-chromosomal form, with downstream tools for segment statistics, pattern finding and distribution plots. Since 2.1.0 the Shiny front end lives inside the package and launches via launchApp() rather than sitting in a separate repository. The latest release is performance work, with profileSimIBD() substantially sped up for dense marker panels and ibdsim() skipping recombination in pedigree branches that cannot affect the result.
Two long-running threads. One is the app as a first-class part of the package, which has been getting input validation, dependency checks and plotting fixes release after release, treating a research GUI as software to be maintained rather than a demo. The other is numerical care: the built-in recombination map was rebuilt in 2.3.0 with better chromosome endpoints and a thinning algorithm that cut it from about 38,000 points to 14,000 without losing accuracy, and IBD segment merging has been made consistent across the realised-coefficient functions. The maintainer flags repeatedly that seeded results may differ across versions, which is the right disclosure for a simulator used in published analyses.
The recent work points at further speed on dense panels and continued hardening of app input handling, both of which have appeared in each of the last several releases. Nothing here signals a new modelling capability on the way.
Plotly ships on two tracks. Plotly Studio, the desktop AI app-builder, releases every one to two weeks and has spent v0.0.80 through v0.0.86 on credential handling, reasoning transparency, personalization and now the reliability of the agent session engine itself. Plotly Cloud is the louder track: since late May it has added viewer-seat pricing, domain verification, per-app compute modes with credit-metered billing, and customer-owned domains with managed TLS.
The Cloud releases are assembling the standard pieces of a hosting business in order — identity first (domain verification, explicitly framed as the step before SSO), then billing (viewer seats, then metered compute credits), and now production-grade serving (custom domains, automatic certificate renewal). Studio is being hardened as the authoring front end that feeds it: Universal Deployment pushed beyond Dash apps, credentials saved once and reused, a Winget channel to widen Windows installs, and in v0.0.86 a rebuilt session engine plus automatic retries so agent runs survive expired tokens. The two tracks converge on one funnel — author in Studio, deploy to Cloud, pay by compute consumed.
The Domain Verification entry names SSO as the next step and places it in the Enterprise tier, so single sign-on is the most likely Cloud release next. Studio should hold its one-to-two-week cadence, with the newly added app thumbnails pointing toward more work on browsing and organizing generated apps.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either ibdsim2 or Plotly.
Omni ships weekly, and almost every week the headline item is an AI feature.
silx settles into maintenance a release after its PySide6 migration
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
OpenCTI spends a release unblocking queues and hardening upserts
See all ibdsim2 alternatives → · See all Plotly alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. Plotly is currently shipping more aggressively (velocity 6.3 vs 2.5), with 1 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Plotly is currently shipping more aggressively (velocity 6.3 vs 2.5), with 1 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top ibdsim2 alternatives in Analytics are ranked by recent ship velocity. Browse the "ibdsim2 alternatives" section above for the current picks, or visit /alternatives/ibdsim2 for the full list with editorial commentary on each.
Top Plotly alternatives in Analytics are ranked by recent ship velocity. Browse the "Plotly alternatives" section above for the current picks, or visit /alternatives/plotly for the full list with editorial commentary on each.